Department of Immunology and Molecular Pathology, Molecular Medicine Unit, Royal Free and University College Medical School, London, UK.
J Perinat Med. 2009;37(5):469-71. doi: 10.1515/JPM.2009.082.
A progressive insulin resistant state develops throughout human pregnancy. Inositol phosphoglycan P-type (P-IPG), a second messenger of insulin, was reported to negatively correlate with the degree of insulin resistance in non-pregnant diabetic subjects. Urinary levels of P-IPG were assessed in insulin resistant states during pregnancy such as gestational diabetes mellitus (GDM, n=44) and type 2 diabetes mellitus (type 2 DM, n=25) and in 69 normal pregnant women. Urinary levels of P-IPG were higher in GDM than controls with a positive trend of release throughout normal pregnancy (P<0.01). P-IPG excretion was higher in diabetic (GDM and type 2 DM) than in healthy women in the second trimester (P<0.05). A higher P-IPG urinary excretion occurs during the second trimester in pregnant women with clinically evident insulin resistance with a positive association with poor glycemic control.
在人类妊娠期间,会逐渐发展出一种胰岛素抵抗状态。胰岛素的第二信使肌醇磷酸聚糖 P 型(P-IPG),据报道与非妊娠糖尿病患者的胰岛素抵抗程度呈负相关。在妊娠期间的胰岛素抵抗状态(如妊娠期糖尿病(GDM,n=44)和 2 型糖尿病(type 2 DM,n=25))和 69 名正常孕妇中评估了 P-IPG 的尿水平。GDM 的 P-IPG 尿水平高于对照组,并且在正常妊娠期间呈阳性释放趋势(P<0.01)。在妊娠中期,糖尿病(GDM 和 type 2 DM)患者的 P-IPG 排泄量高于健康女性(P<0.05)。在临床明显胰岛素抵抗的孕妇中,第二孕期的 P-IPG 尿排泄量较高,与血糖控制不良呈正相关。